Avet-Loiseau, H; Bahlis, NJ; Chng, WJ; Masszi, Tamás; Viterbo, L; Pour, L; Ganly, P; Palumbo, A; Cavo, M; Langer, C; Pluta, A; Nagler, A; Kumar, S; Ben-Yehuda, D; Rajkumar, SV; San-Miguel, J; Berg, D; Lin, J; van de Velde, H; Esseltine, DL; di Bacco, A; Moreau, P; Richardson, PG
(2017)
Certain cytogenetic abnormalities are known to adversely impact outcomes in patients with multiple myeloma (MM). The phase 3 TOURMALINE-MM1 study demonstrated a significant improvement in progression-free survival (PFS) ...